Notices. DEPARTMENT OF JUSTICE
1,114 words·~5 min read·
/register/2011/07/05/2011-16795·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-30-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under the Section to a bulk manufacturer of a controlled substance in Schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacturer of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 CFR 1301.34(a), this is notice that on April 5, 2011, Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle PA, North Carolina 27709, made application by renewal to the Drug Enforcement Administration
(DEA)for registration as an importer of the following basic classes of controlled substances: Drug Schedule 1-(1-Phenylcyclohexyl)pyrrolidine
(7458)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
(7473)I 1-Butyl-3-(1-naphthoyl)indole
(7173)I 1-Pentyl-3-(1-naphthoyl)indole
(7118)I 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) Idole
(7200)I 1-Methyl-4-phenyl-4-propionoxypiperidine
(9661)I 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
(9663)I 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
(7297)I 5-(1,1-Dimethylloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
(7298)I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(7348)I 2,5-Dimethoxy-4-ethylamphetamine
(7399)I 2,5-Dimethoxyamphetamine
(7396)I 3,4,5-Trimethoxyamphetamine
(7390)I 3,4-Methylenedioxyamphetamine
(7400)I 3,4-Methylenedioxymethamphetamine
(7405)I 3,4-Methylenedioxy-N-ethylamphetamine
(7404)I 3-Methylfentanyl
(9813)I 3-Methylthiofentanyl
(9833)I 4-Bromo-2,5-dimethoxyamphetamine
(7391)I 4-Bromo-2,5-dimethoxyphenethylamine
(7392)I 4-Methyl-2,5-dimethoxyamphetamine
(7395)I 4-Methylaminorex (cis isomer)
(1590)I 4-Methoxyamphetamine
(7411)I 5-Methoxy-3,4-methylenedioxyamphetamine
(7401)I 5-Methoxy-N,N-diisopropyltryptamine
(7439)I Acetorphine
(9319)I Acetyl-alpha-methylfentanyl
(9815)I Acetyldihydrocodeine
(9051)I Acetylmethadol
(9601)I Allylprodine
(9602)I Alphacetylmethadol except levo-alphacetylmethadol
(9603)I Alpha-ethyltryptamine
(7249)I Alphameprodine
(9604)I Alphamethadol
(9605)I Alpha-methylfentanyl
(9814)I Alpha-methylthiofentanyl
(9832)I Alpha-methyltryptamine
(7432)I Aminorex
(1585)I Benzethidine
(9606)I Benzylmorphine
(9052)I Betacetylmethadol
(9607)I Beta-hydroxy-3-methylfentanyl
(9831)I Beta-hydroxyfentanyl
(9830)I Betameprodine
(9608)I Betamethadol
(9609)I Betaprodine
(9611)I Bufotenine
(7433)I Cathinone
(1235)I Clonitazene
(9612)I Codeine methylbromide
(9070)I Codeine-N-Oxide
(9053)I Cyprenorphine
(9054)I Desomorphine
(9055)I Dextromoramide
(9613)I Diampromide
(9615)I Diethylthiambutene
(9616)I Diethyltryptamine
(7434)I Difenoxin
(9168)I Dihydromorphine
(9145)I Dimenoxadol
(9617)I Dimepheptanol
(9618)I Dimethylthiambutene
(9619)I Dimethyltryptamine
(7435)I Dioxaphetyl butyrate
(9621)I Dipipanone
(9622)I Drotebanol
(9335)I Ethylmethylthiambutene
(9623)I Etonitazene
(9624)I Etorphine except HCl
(9056)I Etoxeridine
(9625)I Fenethylline
(1503)I Furethidine
(9626)I Gamma Hydroxybutyric Acid
(2010)I Heroin
(9200)I Hydromorphinol
(9301)I Hydroxypethidine
(9627)I Ibogaine
(7260)I Ketobemidone
(9628)I Levomoramide
(9629)I Levophenacylmorphan
(9631)I Lysergic acid diethylamide
(7315)I Marihuana
(7360)I Mecloqualone
(2572)I Mescaline
(7381)I Methaqualone
(2565)I Methcathinone
(1237)I Methyldesorphine
(9302)I Methyldihydromorphine
(9304)I Morpheridine
(9632)I Morphine methylbromide
(9305)I Morphine methylsulfonate
(9306)I Morphine-N-Oxide
(9307)I Myrophine
(9308)I N,N-Dimethylamphetamine
(1480)I N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(9834)I N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(9818)I N-Benzylpiperazine
(7493)I N-Ethyl-3-piperidyl benzilate
(7482)I N-Ethylamphetamine
(1475)I N-Ethyl-1-phenylcyclohexylamine
(7455)I N-Hydroxy-3,4-methylenedioxyamphetamine
(7402)I Nicocodeine
(9309)I Nicomorphine
(9312)I N-Methyl-3-piperidyl benzilate
(7484)I Noracymethadol
(9633)I Norlevorphanol
(9634)I Normethadone
(9635)I Normorphine
(9313)I Norpipanone
(9636)I Para-Fluorofentanyl
(9812)I Parahexyl
(7374)I Peyote
(7415)I Phenadoxone
(9637)I Phenampromide
(9638)I Phenomorphan
(9647)I Phenoperidine
(9641)I Pholcodine
(9314)I Piritramide
(9642)I Proheptazine
(9643)I Properidine
(9644)I Propiram
(9649)I Psilocybin
(7437)I Psilocyn
(7438)I Racemoramide
(9645)I Tetrahydrocannabinols
(7370)I Thebacon
(9315)I Thiofentanyl
(9835)I Tilidine
(9750)I Trimeperidine
(9646)I 1-Phenylcyclohexylamine
(7460)II 1-Piperidinocyclohexanecarbonitrile
(8603)II 4-Anilino-N-phenethyl-4-piperidine
(8333)II Alfentanil
(9737)II Alphaprodine
(9010)II Amobarbital
(2125)II Amphetamine
(1100)II Anileridine
(9020)II Bezitramide
(9800)II Carfentanil
(9743)II Coca Leaves
(9040)II Cocaine
(9041)II Codeine
(9050)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Dihydrocodeine
(9120)II Dihydroetorphine
(9334)II Diphenoxylate
(9170)II Ecgonine
(9180)II Ethylmorphine
(9190)II Etorphine HCl
(9059)II Fentanyl
(9801)II Glutethimide
(2550)II Hydrocodone
(9193)II Hydromorphone
(9150)II Isomethadone
(9226)II Levo-alphacetylmethadol
(9648)II Levomethorphan
(9210)II Levorphanol
(9220)II Lisdexamfetamine
(1205)II Meperidine
(9230)II Meperidine intermediate-A
(9232)II Meperidine intermediate-B
(9233)II Meperidine intermediate-C
(9234)II Metazocine
(9240)II Methadone
(9250)II Methadone intermediate
(9254)II Methamphetamine
(1105)II Methylphenidate
(1724)II Metopon
(9260)II Moramide intermediate
(9802)II Morphine
(9300)II Nabilone
(7379)II Opium, raw
(9600)II Opium extracts
(9610)II Opium fluid extract
(9620)II Opium tincture
(9630)II Opium poppy/Poppy Straw
(9650)II Poppy Straw Concentrate
(9670)II Opium, granulated
(9640)II Oxycodone
(9143)II Oxymorphone
(9652)II Pentobarbital
(2270)II Phenazocine
(9715)II Phencyclidine
(7471)II Phenmetrazine
(1631)II Phenylacetone
(8501)II Piminodine
(9730)II Powdered opium
(9639)II Racemethorphan
(9732)II Racemorphan
(9733)II Remifentanil
(9739)II Secobarbital
(2315)II Sufentanil
(9740)II Tapentadol
(9780)II Thebaine
(9333)II The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse
(NIDA)for research activities. No comments, objections, or requests for any hearings will be accepted on any application for registration or re-registration to import crude opium, poppy straw, concentrate of poppy straw, and coca leaves. As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952 (a)(2)(B)) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 4, 2011. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR § 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the **Federal Register** on September 23, 1975, 40 FR 43745-46, all applicants for registration to import a basic classes of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and
(f)are satisfied. Dated: June 23, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011-16795 Filed 7-1-11; 8:45 am]
Connectionstraces to 6
Traces to 6 documents
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 6Cited by 0 across 0 sources